Comparison of the efficacy of AZT and PMEA treatment against acute SIVmne infection in macaques
- 5 February 1994
- journal article
- research article
- Published by Wiley in Journal of Medical Primatology
- Vol. 23 (2-3), 175-183
- https://doi.org/10.1111/j.1600-0684.1994.tb00119.x
Abstract
The antiretroviral drugs azidothymidine (AZT) and 9-(-2-phosphonyl-methoxyethyl)adenine (PMEA) were individually tested for prevention of simian immunodeficiency virus (SIVmne) infection in macaques (Macaca fascicularis). Macaques were pretreated with either drug before inoculation with SIVmne, and drug treatment was continued for four weeks. The virus, antibody, and clinical status of the macaques was monitored for up to 36 weeks following inoculation. While AZT prophylaxis resulted in reduced virus load in some macaques, PMEA prophylaxis was highly efficacious in preventing acute SIVmne infection.Keywords
This publication has 23 references indexed in Scilit:
- Quiescent T Lymphocytes as an Inducible Virus Reservoir in HIV-1 InfectionScience, 2006
- Effects of Initiation of 3'-Azido,3'-Deoxythymidine (Zidovudine) Treatment at Different Times after Infection of Rhesus Monkeys with Simian Immunodeficiency VirusThe Journal of Infectious Diseases, 1993
- Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.JCI Insight, 1993
- Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160Science, 1992
- 9-(2-phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeysAIDS, 1991
- Nonhuman Primate Models for Evaluation of AIDS TherapyAnnals of the New York Academy of Sciences, 1990
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990
- Simian immunodeficiency viruses and their relationship to the human immunodeficiency virusesAIDS, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- A novel selective broad-spectrum anti-DNA virus agentNature, 1986